Altimmune, Inc. - COM NEW (ALT)

Historical Portfolio Holders from Q3 2018 to Q1 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	42 M	$428 M	+$96.9 M	6.58 M	11.2 M	$10.18	159
2023 Q4	32.3 M	$363 M	+$81.9 M	9.9 M	15.3 M	$11.25	139
2023 Q3	30.1 M	$78.3 M	-$14.2 M	570 K	1.47 M	$2.60	110
2023 Q2	35.2 M	$124 M	-$30 M	622 K	1.35 M	$3.53	115
2023 Q1	39.7 M	$167 M	-$115 M	12.5 M	22.4 M	$4.22	129
2022 Q4	46.7 M	$768 M	+$25.9 M	4.79 M	47.6 M	$16.45	125
2022 Q3	45.9 M	$586 M	+$85.3 M	8.17 M	38.7 M	$12.77	119
2022 Q2	39.9 M	$467 M	+$78.7 M	1.26 M	11.5 M	$11.70	105
2022 Q1	33.6 M	$207 M	+$7.11 M	342 K	4.64 M	$6.09	93
2021 Q4	31.2 M	$285 M	-$18.3 M	4.88 M	8.1 M	$9.16	95
2021 Q3	31.9 M	$361 M	+$58.6 M	7.59 M	24.8 M	$11.31	112
2021 Q2	27.2 M	$268 M	+$16.7 M	7.88 M	5.77 M	$9.85	103
2021 Q1	23.8 M	$336 M	+$48.3 M	8.09 M	9.47 M	$14.13	92
2020 Q4	19.2 M	$217 M	-$28.7 M	5.68 M	3.79 M	$11.28	80
2020 Q3	21.9 M	$289 M	+$115 M	3.2 M	4.82 M	$13.20	68
2020 Q2	13.3 M	$143 M	+$125 M	1.03 M	9.77 M	$10.71	55
2020 Q1	1.58 M	$5.06 M	+$1.22 M	131 K	475 K	$3.21	20
2019 Q4	1.28 M	$2.42 M	+$315 K	0	40 K	$1.89	21
2019 Q3	1.11 M	$2.17 M	+$160 K	28 K	39 K	$1.95	21
2019 Q2	1.03 M	$2.46 M	-$456 K	37 K	69 K	$2.38	14
2019 Q1	1.11 M	$3.23 M	+$1.23 M	339 K	329 K	$2.90	12
2018 Q4	807 K	$1.66 M	+$930 K		61 K	$2.06	17
2018 Q3	194 K	$852 K	+$852 K			$4.40	5